Neurogenetics explores the genetic underpinnings of neurological disorders, examining how inherited and spontaneous genetic mutations contribute to conditions like epilepsy, Huntington's disease, and Alzheimer's. The field has made significant strides in identifying specific genes involved in neurodegenerative diseases, allowing for better diagnostic tools and the potential for gene-based therapies. Advances in next-generation sequencing and CRISPR technology are enabling researchers to study gene function and the effects of genetic variations on the nervous system at unprecedented levels of detail. Neurogenetics also holds promise for personalized treatment approaches, where genetic profiles inform targeted interventions, improving outcomes for individuals with genetically linked neurological conditions. As the field evolves, the integration of genetic counseling is playing a crucial role in guiding patients and families through the complexities of genetic disorders.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Psychogenic Non-Epileptic Seizures (PNES) also known as Functional Seizures (FS)
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Futurey on neurology
Luiz Moutinho, University of Suffolk, United Kingdom
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Predictors of neurological recovery following traumatic spinal cord
W S El Masri, Keele University, United Kingdom
Title : The vision neurology as bio-recursion and brain-blockchain
Dobilas Kirvelis, Lithuanian Scientific Society, Lithuania